Syed Abutalib

Syed Abutalib practices at Aurora St. Luke's Medical Center in Milwaukee, Wisconsin, part of Advocate Health.

Syed Abutalib's NPI, 1114183290, was assigned on July 29, 2008. Syed Abutalib graduated from Dow University of Health Sciences in 1998. Syed Abutalib's Wisconsin license number on file is 101070.

Syed Abutalib's primary practice is Aurora St. Luke's Medical Center, at 2900 W Oklahoma Ave, Milwaukee, WI 53215 in Milwaukee County. The practice phone is (414) 649-6000.

Syed Abutalib's primary practice is Aurora St. Luke's Medical Center in Milwaukee, Wisconsin, part of Advocate Health. Syed Abutalib is also affiliated with Northwest Community Hospital. The medical group on file is Aurora St. Luke's Medical Center. Dmand AI also links Syed Abutalib to 3 more hospitals, 5 medical groups, 2 group practices and clinics, 1 home health agency and 1 therapy and rehab clinic, each named with a free account. Syed Abutalib's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Syed Abutalib practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Syed Abutalib's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Syed Abutalib is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Syed Abutalib's licenses on file in 3 states: Wisconsin, Illinois and Georgia.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma and multiple myeloma among the conditions Syed Abutalib treats.

CMS data shows 874 Medicare services from Syed Abutalib across 6 procedure codes in 2024, for 138 Medicare patients. Medicare paid $92,123 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Syed Abutalib in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Syed Abutalib's median patient age at 70, with 47% women.

In 2024, Syed Abutalib wrote 740 Medicare Part D claims for 106 patients. 78% of them were for generic drugs. CMS names the drug for 476 of them, across 22 drugs with 11 or more claims each, at $260,278 in total drug cost. In 2023, CMS named 368 claims across 14 drugs.

Syed Abutalib accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Syed Abutalib, published from 2007 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation, Antineoplastic Agents and Hemorrhage. Syed Abutalib's most frequent co-authors are Miguel A. Perales, MD, Paul Andrew Carpenter and Jean M. Connors, MD.

CMS Open Payments shows 575 general payments to Syed Abutalib from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. AstraZeneca Pharmaceuticals LP paid the most, $104,895.

Syed Abutalib graduated from Dow University of Health Sciences in 1998. Syed Abutalib is a member of American Society of Clinical Oncology, American Society of Hematology, American Society of Transplantation & Cellular Therapy and Educational Executive Committee Member.

Syed Abutalib is in network with 20 carriers, including Elevance, HCSC and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.